Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Classics in chemical neuroscience: clozapine.

Wenthur CJ, Lindsley CW.

ACS Chem Neurosci. 2013 Jul 17;4(7):1018-25. doi: 10.1021/cn400121z. Review.

2.

Clozapine and negative symptoms. An open study.

Llorca PM, Lancon C, Farisse J, Scotto JC.

Prog Neuropsychopharmacol Biol Psychiatry. 2000 Apr;24(3):373-84.

PMID:
10836486
3.

A systematic review of the evidence of clozapine's anti-aggressive effects.

Frogley C, Taylor D, Dickens G, Picchioni M.

Int J Neuropsychopharmacol. 2012 Oct;15(9):1351-71. doi: 10.1017/S146114571100201X. Review.

PMID:
22339930
4.

[Dopamine D4-receptor variants, schizophrenia and clozapine therapy].

Ewald HL, Mors NP, Rosenberg R.

Ugeskr Laeger. 1996 Jun 17;158(25):3601-3. Review. Danish.

PMID:
8693618
6.

Treatment-resistant schizophrenia--the role of clozapine.

Meltzer HY.

Curr Med Res Opin. 1997;14(1):1-20. Review.

PMID:
9524789
7.

Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine.

Arranz MJ, Collier DA, Munro J, Sham P, Kirov G, Sodhi M, Roberts G, Price J, Kerwin RW.

Neurosci Lett. 1996 Oct 18;217(2-3):177-8.

PMID:
8916101
8.

Optimizing treatment with clozapine.

Conley RR.

J Clin Psychiatry. 1998;59 Suppl 3:44-8. Review.

9.

The effects of clozapine on cognitive functioning in schizophrenia.

McGurk SR.

J Clin Psychiatry. 1999;60 Suppl 12:24-9. Review.

10.

Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?

Carpenter WT Jr, Zito JM, Vitrai J, Volavka J.

Biol Psychiatry. 1998 Jan 15;43(2):79-83.

PMID:
9474440
11.

Clozapine: current status and role in the pharmacotherapy of schizophrenia.

Remington GJ, Addington D, Collins EJ, Jones BD, Lalonde P, MacCrimmon DJ, MacEwan GW.

Can J Psychiatry. 1996 Apr;41(3):161-6.

PMID:
8722645
12.

Effectiveness of clozapine in hospitalised people with chronic neuroleptic-resistant schizophrenia.

Avnon M, Rabinowitz J.

Br J Psychiatry. 1995 Dec;167(6):760-4. Review.

PMID:
8829743
13.

Clozapine: a clinical review of adverse effects and management.

Iqbal MM, Rahman A, Husain Z, Mahmud SZ, Ryan WG, Feldman JM.

Ann Clin Psychiatry. 2003 Mar;15(1):33-48. Review.

PMID:
12839431
14.

The expanding indications for clozapine.

Young CR, Longhurst JG, Bowers MB Jr, Mazure CM.

Exp Clin Psychopharmacol. 1997 Aug;5(3):216-34. Review.

PMID:
9260069
15.

Clozapine versus typical neuroleptic medication for schizophrenia.

Wahlbeck K, Cheine M, Essali MA.

Cochrane Database Syst Rev. 2000;(2):CD000059. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD000059.

PMID:
10796289
16.

Clozapine use in children and adolescents.

Gogtay N, Rapoport J.

Expert Opin Pharmacother. 2008 Feb;9(3):459-65. doi: 10.1517/14656566.9.3.459 . Review.

PMID:
18220495
17.
18.

Clozapine's effects on body weight and resting metabolic rate: a case series.

Procyshyn RM, Chau A, Tse G.

Schizophr Res. 2004 Feb 1;66(2-3):159-62.

PMID:
15061248
19.
20.

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

Malhotra AK, Adler CM, Kennison SD, Elman I, Pickar D, Breier A.

Biol Psychiatry. 1997 Oct 15;42(8):664-8.

PMID:
9325559
Items per page

Supplemental Content

Support Center